Stock LSL LSL PHARMA GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

News LSL Pharma Group Inc.

Equities

LSL

CA50190N1042

End-of-day quote Toronto S.E.
Other stock markets
 03:30:00 19/06/2024 am IST 		5-day change 1st Jan Change
0.49 CAD 0.00% Intraday chart for LSL Pharma Group Inc. 0.00% +1.03%
18/06 LSL Pharma Group Inc. acquired Virage Santé inc. CI
05/06 LSL Pharma to Raise $4.5 Million Via Private Placements MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LSL Pharma Group Completes the Acquisition of Virage Santé
GL
LSL Pharma Group Completes the Acquisition of Virage Santé
AQ
LSL Pharma Group Inc. acquired Virage Santé inc.
CI
LSL Pharma Group Announces Engagement of Red Cloud Securities
GL
LSL Pharma Group Announces Engagement of Red Cloud Securities
AQ
LSL Pharma to Raise $4.5 Million Via Private Placements
MT
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
GL
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $4.5 Million
AQ
LSL Pharma Group Inc. announced that it expects to receive CAD 3 million in funding
CI
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
GL
LSL Pharma Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
GL
LSL Pharma to Acquire Quebec Competitor for $2.5 Million to Expand Natural-Product Offerings
MT
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
GL
LSL Pharma Group Inc. entered into a binding Letter of Intent to acquire Target Co for CAD 2.5 million.
CI
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
GL
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
AQ
LSL Pharma Group Brief: Said Earlier Wednesday It Secured $3.8 Million As the Second And Final Tranche Of Its Private Placement Of Units
MT
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
GL
LSL Pharma Group Inc. announced that it has received CAD 6.479426 million in funding from Alfera Pharmaceuticals, LLC
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LSL Stock
  4. News LSL Pharma Group Inc.